» Authors » Anna A Abramova

Anna A Abramova

Explore the profile of Anna A Abramova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 16
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Butranova O, Terekhina E, Zyryanov S, Gildeeva G, Abramova A, Kustov Y, et al.
Biomedicines . 2025 Jan; 12(12. PMID: 39767557
Background/objectives: Pulmonary fibrosis (PF) results in a progressive decline of lung function due to scarring. Drugs are among the most common causes of PF. The objective of our study was...
2.
Zhdanov D, Gladilina Y, Blinova V, Abramova A, Shishparenok A, Eliseeva D
Biomedicines . 2024 May; 12(5). PMID: 38790984
Forkhead box protein 3 (FoxP3) is a key transcription factor responsible for the development, maturation, and function of regulatory T cells (Tregs). The FoxP3 pre-mRNA is subject to alternative splicing,...
3.
Polskaya N, Basova A, Razvaliaeva A, Yakubovskaya D, Vlasova N, Abramova A
Consort Psychiatr . 2024 Jan; 4(2):65-77. PMID: 38250646
Background: Eating disorders (EDs) are associated with a risk of premature death, as well as suicidal and self-injurious behavior. A low or high body mass index (BMI) and weight control...
4.
Blinova V, Gladilina Y, Abramova A, Eliseeva D, Vtorushina V, Shishparenok A, et al.
Cells . 2024 Jan; 13(1). PMID: 38201281
The maturation, development, and function of regulatory T cells (Tregs) are under the control of the crucial transcription factor Forkhead Box Protein 3 (FoxP3). Through alternative splicing, the human FoxP3...
5.
Abramova A, Attarian H, Dolgova S, Belyakova-Bodina A, Iakovenko E, Broutian A
Sleep Sci . 2021 Dec; 14(Spec 1):97-100. PMID: 34917281
Both non-epileptic sleep disturbances and epilepsy are common in patients with mucopolysaccharidoses (MPS), so diagnosis of sleep-related hypermotor epilepsy in these patients is a tackling issue. We present a case...
6.
Zakharova M, Abramova A
Neural Regen Res . 2021 Jun; 17(1):65-73. PMID: 34100429
Amyotrophic lateral sclerosis is a fatal neurodegenerative disease characterized by progressive muscle wasting, breathing and swallowing difficulties resulting in patient's death in two to five years after disease onset. In...